The Mosaic Company said net income for the quarter ended June 30, 2025 was $410.7 million, or $1.29 per diluted share, compared to a net loss of $(161.5) million, or $(0.50) per diluted share, in the prior year period. The company said a foreign currency transaction gain of $169.4 million and an unrealized mark-to-market gain of $216 million on Ma'aden shares favorably impacted net income.

1. 01

   The Mosaic Company said net income for the quarter ended June 30, 2025 was $410.7 million, or $1.29 per diluted share, compared to a net loss of $(161.5) million, or $(0.50) per diluted share, in the prior year period. The company said a foreign currency transaction gain of $169.4 million and an unrealized mark-to-market gain of $216 million on Ma'aden shares favorably impacted net income.

2. 02

   The Mosaic Company said operating loss in its Phosphate segment for the quarter declined to $(8) million from operating earnings of $133 million in the prior year period. The company explained that increased provisions for water treatment costs and an increase to asset retirement obligations for closed facilities more than offset the benefit of improved pricing.

3. 03

   The Mosaic Company said operating earnings for the quarter were $194 million in the Potash segment, compared to $174 million in the prior year, and $109 million in the Mosaic Fertilizantes segment, compared to $61 million in the prior year. The company said higher average selling prices in both segments favorably impacted operating results.

4. 04

   The Mosaic Company said net cash provided by operating activities for the 6 months ended June 30, 2025 was $652.4 million, compared to $767.0 million in the prior year period, and net cash used in investing activities was $659.3 million. Capital expenditures for the period were $645.4 million and dividend payments were $141.0 million.

Key figures

Quarter ended June 30, 2025

Revenue

$3.0B

Operating income

$244M

Net income

$411M

EPS

$1.29

Gross profit

$519M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.